Cryo Catheter Ablation Is Now Available for Paroxysmal Atrial Fibrillation Patients in the US

Rate This

The U.S. Food and Drug Administration (FDA) has approved the Medtronic Arctic Front® Cardiac CryoAblation Catheter system for the treatment of paroxysmal atrial fibrillation. This is the first cryo (freezing) catheter ablation system to receive approval in the US. Approval was based on the results of the STOP AF (Sustained Treatment of Paroxysmal Atrial Fibrillation) clinical trial that reported higher success at one year than medications along with reduced AF symptoms and improved quality of life.

To learn more, see the story below, and then please come back here to post your thoughts and comments below.

Cryo Catheter Ablation System Approved for Treatment of Paroxysmal Atrial Fibrillation in the U.S.

Mellanie True Hills Bio

Launch of Atrial Fibrillation Resource, the Silver Book®: Thrombosis, on ...

Atrial Fibrillation Patient to Speak at Western Atrial Fibrillation Symposium

Congress Embarks on Efforts to Cut the Deficit — Guest Post by WomenHeart

Atrial Fibrosis, Not Afib Type, Linked to Atrial Fibrillation Strokes

Add a CommentComments

There are no comments yet. Be the first one and get the conversation started!

Mellanie True Hills Expert View Profile Send Message

We value and respect our HERWriters' experiences, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice, although we hope you can gain knowledge from their insight.